Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers. [electronic resource]
Producer: 20131111Description: 2240-7 p. digitalISSN:- 1557-3265
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Aged, 80 and over
- Biopsy
- CD56 Antigen -- analysis
- DNA Mutational Analysis -- methods
- Drug Resistance, Neoplasm -- genetics
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride
- Female
- Gefitinib
- Humans
- Immunohistochemistry
- In Situ Hybridization, Fluorescence
- Kaplan-Meier Estimate
- Ki-67 Antigen -- analysis
- Lung -- drug effects
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Mutation
- Protein Kinase Inhibitors -- therapeutic use
- Proto-Oncogene Proteins c-met -- genetics
- Quinazolines -- therapeutic use
- Receptor, ErbB-2 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.